Name: AVBP Balance Sheet - Arrivent Biopharma Assets & Debt | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Total Assets, Current Assets, Cash and Equivalents, Total Liabilities, Long-term Debt, Short-term Debt, Shareholders Equity, Working Capital, Book Value Per Share

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

AVBP - Arrivent Biopharma, Inc.

USD | NASDAQ | Healthcare

AVBP Balance Sheet - Arrivent Biopharma Assets & Debt | Ledgeburg

(in millions of USD)	FY2025	FY2024	FY2023	FY2022
Cash And Short Term Investments
Cash And Equivalents	45.5	74.3	150.4	-
Restricted Cash	-	-	-	-
Short Term Investments	267.3	144.6	-	-
Cash And Short Term Investments	312.8	218.9	150.4	-
Receivables
Accounts Receivable	-	-	-	-
Current Assets
Inventory	-	-	-	-
Prepaid Expenses	20.1	8.1	9.6	-
Other Current Assets	-	-	-	-
Non-Current Assets
Property, Plant & Equipment Gross	-	-	-	-
Accumulated Depreciation	-	-	-	-
Property,Plant & Equipment Net	-	-	-
Current Liabilities
Accounts Payable	5.9	3.8	4.5	-
Short Term Debt	-	-	-	-
Deferred Revenue Current	-	-	-	-
Non-Current Liabilities
Long Term Debt	-	-	-	-
Operating Lease Liabilities Non-Current	-	0.0	0.2	-
Deferred Revenue Non-Current	-	-	-
Common Equity
Common Stock	0.0	0.0	-	-
Additional Paid In Capital	711.8	496.2	4.7	-
Retained Earnings	(404.6)	(238.3)	(157.8)
Supplementary Data
Total Debt	-	-	-	-
Net debt	-	-	-	-
Working Capital	307.0	209.7	148.3	-

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22
Cash And Short Term Investments
Cash And Equivalents	62.1	45.5

Current Assets
Inventory	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Prepaid Expenses	22.3	20.1	21.0	14.5	9.7	8.1	9.5	9.8	10.1	9.6	-	-	-	-
Other Current Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Assets Held For Sale	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Current Assets	348.7	332.9	321.2	250.1	185.8	227.0	292.4	308.5	327.5	160.0	-	-	-	-

Non-Current Assets
Property, Plant & Equipment Gross	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accumulated Depreciation	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Property,Plant & Equipment Net	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Long Term Investments	-	-	5.1	18.8	29.4	47.7	-	-	-	-	-	-	-	-
Equity Method Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Goodwill	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Intangible Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Lease Right Of Use Assets	0.4	0.0	0.0	0.1	0.1	0.2	0.2	0.2	0.3	0.3	-	-	-	-
Deferred Tax Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Current Assets	0.2	0.2	0.2	0.5	0.2	0.1	0.1	0.1	0.1	0.1	-	-	-	-
Total Non-Current Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	349.3	333.2	326.6	269.5	215.5	274.9	292.7	308.9	327.8	163.1	-	-	-	-

Current Liabilities
Accounts Payable	8.7	5.9	5.9	4.1	4.4	3.8	4.6	3.8	4.1	4.5	-	-	-	-
Short Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue Current	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Lease Liabilities Current	0.1	0.0	0.1	0.1	0.1	0.2	0.2	0.2	0.1	0.1	-	-	-	-
Accrued Expenses	16.2	20.0	15.6	15.5	8.5	13.3	10.4	8.1	5.7	7.0	-	-	-	-
Other Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Current Liabilities	25.0	25.9	21.6	19.6	13.0	17.3	15.2	12.1	10.0	11.6	-	-	-	-

Non-Current Liabilities
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Lease Liabilities Non-Current	0.3	-	-	-	-	0.0	0.1	0.1	0.1	0.2	-	-	-	-
Deferred Revenue Non-Current	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Tax Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Pension Obligations	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non-Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	25.3	25.9	21.6	19.6	13.0	17.3	15.2	12.2	10.1	11.8	-	-	-	-